Cytidine deaminase inhibitor
This page covers all Cytidine deaminase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cytidine deaminase.
Targets
Marketed (1)
- DAC · dr hab. n. med. Agnieszka Wierzbowska · Oncology
DAC is a cytidine deaminase inhibitor that enhances the activity of cytarabine by preventing its inactivation.